Agenus launches SaponiQx subsidiary
September 10, 2021 -- Agenus is launching a new subsidiary dedicated to novel adjuvant discovery and vaccine design, the company announced. Read More
ONK Therapeutics awarded patents for CISH knockout in NK cells
September 9, 2021 -- The U.S. Patent and Trademark Office has granted ONK Therapeutics patents covering the company's cytokine-inducible SH2-containing (CISH) knockout in NK cells, irrespective of the source of the NK cells. Read More
Mammoth raises $195M for CRISPR products
September 9, 2021 -- Mammoth Biosciences has raised $195 million in financing that will enable the company to broaden its toolkit of next-generation CRISPR systems. Read More
Precision and Iecure ink collaboration deal
September 9, 2021 -- Precision BioSciences and Iecure have entered a license and collaboration agreement to develop gene editing therapies. Read More
Boehringer, Twist to collaborate on antibody discovery
September 9, 2021 -- Boehringer Ingelheim and Twist Bioscience have entered a research collaboration to discover therapeutic antibodies against multiple targets. Read More
Mission Bio updates platform to expand heme-onc research
September 8, 2021 -- Mission Bio has improved its Tapestri platform to expand its accessibility and utility in hematologic oncology (heme-onc) research. Read More
INanoBio creates new device to speed up DNA sequencing
September 8, 2021 -- Startup INanoBio has developed a new field effect nanopore transistor device, which represents a step toward faster DNA sequencing. Read More
Adaptimmune collaborates with Genentech on allogeneic T-cell therapies
September 8, 2021 -- Adaptimmune Therapeutics is joining forces with Genentech, a Roche company, to develop and commercialize allogeneic T-cell therapies for multiple oncologic applications. Read More
Avantor to acquire Masterflex for $2.9B
September 7, 2021 -- Avantor has agreed to purchase the Masterflex bioprocessing business and related assets of Antylia Scientific in an all-cash deal valued at $2.9 billion. Read More
Emulate nabs $82M to scale its organ-on-a-chip business
September 7, 2021 -- Emulate has secured $82 million in a series E financing round led by existing investor Northpond Ventures. Read More
Conferences
BioTech Pharma Summit
September 27-28
Porto Portugal
Infectious Diseases (ID) Week 2021
September 29 - October 3
San Diego, California United States
Imaging Mass Spectrometry Society (IMSS) 3 in 2021
October 3-6
Colorado Springs, Colorado United States
Cell & Gene Meeting on the Mesa
October 10-14
Carlsbad, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter